Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huro Probiotics is a biotechnology company based in Vietnam that specializes in the research, development, and large-scale production of spore-forming probiotics. The company's core technology is built around the Bacillus subtilis HU58 strain, which was developed in collaboration with Royal Holloway, University of London. This specific strain is highly resistant to heat and gastric acid, allowing for its application in both pharmaceutical supplements and functional food products. Huro operates a state-of-the-art, GMP-certified manufacturing facility and provides contract manufacturing services to global partners. Their product pipeline includes solutions for digestive health, respiratory infections, and immune system modulation. As a subsidiary of The PAN Group, Huro leverages an extensive distribution network to commercialize its probiotic innovations across Southeast Asia and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huro.